SEC 13F Intelligence

Octagon Capital Advisors LP / IMVT

Octagon Capital Advisors LP’s Immunovant Inc Position

Does Octagon Capital Advisors LP own Immunovant Inc (IMVT)? Not currently — the last reported position was 273.3K shares worth $9M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$9M
Q1 2024
Shares
273.3K
% of Portfolio
+1.06%
Quarters Held
6
position exited

Position History IMVT

Reported value by quarter
Q4 ’21: $5MQ4 ’21Q1 ’22: $8MQ1 ’22Q2 ’22: $2MQ2 ’22Q3 ’22: $3MQ3 ’22Q4 ’23: $12MQ4 ’23Q1 ’24: $9MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2024273.3K$9M+1.06%
Q4 2023273.3K$12M+1.84%
Q3 2022579.1K$3M+0.56%
Q2 2022579.1K$2M+0.60%
Q1 20221.48M$8M+1.76%
Q4 2021572.9K$5M+0.95%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of IMVT.